Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Quanex Building Products Corporation due to alleged violations of federal securities laws, particularly related to misleading statements about the company's operational issues and maintenance practices [2][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Quanex between December 12, 2024, and September 5, 2025, to discuss their legal options [1]. - There is a deadline of November 18, 2025, for investors to seek the role of lead plaintiff in a federal securities class action against Quanex [2]. Group 2: Allegations Against Quanex - The complaint alleges that Quanex's tooling and equipment maintenance policies in its Tyman Mexico facility were significantly underinvested, leading to degraded conditions [4]. - It is claimed that these operational issues were known to the company, which misled investors about its business prospects [4]. Group 3: Financial Impact - On September 4, 2025, Quanex reported a diluted EPS of ($6.04), a significant decline from $0.77 in the prior year period, and an adjusted EBITDA of $70.30 [5]. - The CEO indicated that operational challenges in the Tyman facility negatively impacted EBITDA by almost $5 million in the third quarter of 2025 [6]. - Following the announcement of these issues, Quanex's stock price fell by 13.1% to $18.18 per share on September 5, 2025, and continued to decline by 10.9% to $16.20 per share on September 8, 2025 [6].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options If you suffered losses in Quanex between December 12, 2024 and September 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, ...

Core Viewpoint - A class action lawsuit has been filed against Quanex Building Products Corporation for alleged misleading statements and failure to disclose significant issues regarding its operations during the Class Period from December 12, 2024, to September 5, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Quanex's tooling and equipment maintenance procedures in its Tyman Mexico facility were significantly underinvested, leading to degraded conditions [5]. - It is alleged that these conditions were near catastrophic levels, which would likely incur significant costs and delay expected benefits from the Tyman integration [5]. - The lawsuit asserts that Quanex had previously identified these issues, and the positive statements made by the defendants regarding the company's business and prospects were materially misleading [5]. Group 2: Investor Information - Investors who purchased Quanex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by November 18, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Investors in Quanex Building Products Corporation have the opportunity to lead a securities fraud class action lawsuit due to substantial losses incurred as a result of undisclosed operational issues [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that from December 12, 2024, to September 5, 2025, the defendants failed to disclose significant underinvestment in tooling and equipment maintenance at the Tyman Mexico facility [3]. - It is claimed that the conditions of the tooling and equipment had degraded to near catastrophic levels, which would likely incur significant costs and delay expected benefits from the Tyman integration [3]. - The complaint also states that Quanex had previously identified these issues, making the defendants' positive statements about the company's business and prospects materially misleading [3]. Investor Participation - Investors who suffered losses in Quanex Building Products Corporation are encouraged to contact the Law Offices of Howard G. Smith before November 18, 2025, to participate in the ongoing lawsuit [2][4]. - Participation does not require immediate action; investors may choose to retain counsel or remain absent from the class action [5].

Core Viewpoint - Class action lawsuits have been filed against several publicly-traded companies, alleging that these companies made materially false and misleading statements regarding their business operations and prospects, which led to investor losses [1]. Group 1: Cytokinetics, Incorporated (NASDAQ: CYTK) - The class period for Cytokinetics is from December 27, 2023, to May 6, 2025, with a lead plaintiff deadline of November 17, 2025 [2]. - Allegations include the failure to disclose the omission of a Risk Evaluation and Mitigation Strategy (REMS) from the initial New Drug Application (NDA), which resulted in a three-month delay in FDA approval processes [2]. - Defendants' positive statements about the company's business were deemed materially misleading due to these omissions [2]. Group 2: Quanex Building Products Corporation (NYSE: NX) - The class period for Quanex is from December 12, 2024, to September 5, 2025, with a lead plaintiff deadline of November 18, 2025 [4]. - The complaint alleges that the company underinvested in tooling and equipment maintenance, leading to degraded conditions that could incur significant costs and delay expected benefits from integration efforts [4]. - Positive statements made by the defendants regarding the company's operations were found to lack a reasonable basis due to these undisclosed issues [4]. Group 3: Jasper Therapeutics, Inc. (NASDAQ: JSPR) - The class period for Jasper is from November 30, 2023, to July 3, 2025, with a lead plaintiff deadline of November 18, 2025 [6]. - Allegations include the lack of necessary controls to ensure third-party manufacturers complied with current Good Manufacturing Practices (cGMP), which could negatively impact clinical trial results and the company's product prospects [6]. - Defendants' positive statements about the company's business and financial prospects were considered materially misleading due to these failures [6]. Group 4: KBR, Inc. (NYSE: KBR) - The class period for KBR is from May 6, 2025, to June 19, 2025, with a lead plaintiff deadline of November 18, 2025 [8]. - The complaint alleges that the company misled investors about the partnership with TRANSCOM, despite knowing of material concerns regarding HomeSafe's ability to fulfill contract obligations [8]. - Positive statements made by the defendants regarding the company's operations were found to lack a reasonable basis due to these undisclosed concerns [8].

Group 1 - A class action lawsuit has been filed on behalf of purchasers of securities of Quanex Building Products Corporation (NYSE: NX) for the period between December 12, 2024, and September 5, 2025 [1] - Investors who purchased Quanex securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The Rosen Law Firm has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors and being ranked highly for its settlements [4] Group 2 - The lawsuit alleges that Quanex made false and misleading statements regarding its tooling and equipment maintenance procedures, which were significantly underinvested [5] - It is claimed that the conditions of Quanex's tooling and equipment had degraded to near catastrophic levels, leading to significant costs and delays in expected benefits from the Tyman integration [5] - The lawsuit asserts that Quanex had previously identified these issues, and the positive statements made by the defendants about the company's business and prospects were materially misleading [5]

Core Viewpoint - A class action lawsuit has been filed against Quanex Building Products Corporation for alleged violations of securities laws, specifically related to misleading statements about the condition of its equipment and the financial implications of necessary repairs [1][2]. Company Summary - The lawsuit claims that Quanex made false and misleading statements regarding its operational capabilities, particularly concerning the maintenance of equipment at its Tyman Mexico facility [2]. - The company is accused of failing to maintain its equipment properly, which has led to the need for expensive repairs that contradict previous claims about integration benefits [2]. - The class period for the lawsuit is defined as December 12, 2024, to September 5, 2025, with a deadline for lead plaintiff appointments set for November 18, 2025 [2]. Investor Information - Shareholders who purchased shares during the specified class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not a requirement for participation in any recovery [2][3]. - Once registered, shareholders will receive updates through a portfolio monitoring software at no cost [3].

Core Viewpoint - Quanex Building Products Corporation is facing a class action lawsuit due to significant operational issues in its Tyman facility in Mexico, which have adversely affected its financial performance and misled investors about the company's operational health [1][4]. Financial Performance - For Q3 2025, Quanex reported a diluted EPS of ($6.04), a significant decline from $0.77 in the same period the previous year [2]. - The adjusted EBITDA for the same quarter was reported at $70.30 million [2]. - The operational challenges in the Tyman facility negatively impacted EBITDA in the Hardware Solutions segment by almost $5 million during Q3 2025 [3]. Stock Market Reaction - Following the announcement of the financial results, Quanex's stock price fell by $2.73, or 13.1%, closing at $18.18 per share on September 5, 2025 [3]. - The stock continued to decline, dropping an additional $1.98, or 10.9%, to close at $16.20 per share on September 8, 2025 [3]. Lawsuit Details - The class action lawsuit alleges that the company made materially false and misleading statements regarding its business operations and failed to disclose significant operational issues in the Tyman facility [4]. - Specific allegations include underinvestment in tooling and equipment maintenance, leading to degraded conditions and increased costs, which were not communicated to investors [4]. Legal Action Timeline - Investors who purchased Quanex securities during the class period (December 12, 2024, to September 5, 2025) have until November 18, 2025, to file a lead plaintiff motion in the class action lawsuit [1][5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Quanex Building Products Corporation due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by November 18, 2025 [4][10]. Group 1: Allegations Against Quanex - The complaint alleges that Quanex and its executives made false or misleading statements and failed to disclose significant underinvestment in tooling and equipment maintenance at its Tyman Mexico facility [6]. - It is claimed that the conditions of the tooling and equipment had degraded to near catastrophic levels, leading to significant costs and delays in expected benefits from the Tyman integration [6]. - The complaint also states that Quanex had previously identified these issues, which rendered the company's positive statements about its business and operations materially misleading [6]. Group 2: Financial Impact - On September 4, 2025, Quanex reported a diluted EPS of ($6.04), a significant decline from $0.77 in the prior year period, and an adjusted EBITDA of $70.30 [7]. - The company disclosed ongoing operational issues related to the Tyman business that impacted results more than expected during the third quarter of 2025 [7]. - During an earnings call on September 5, 2025, CEO George Wilson noted that operational challenges negatively impacted EBITDA in the Hardware Solutions segment by almost $5 million in the third quarter alone [8]. Group 3: Stock Price Reaction - Following the announcement of the financial results and operational issues, Quanex's stock price fell by $2.73, or 13.1%, closing at $18.18 per share on September 5, 2025, with unusually heavy trading volume [8]. - The stock continued to decline, falling by $1.98 or 10.9% to close at $16.20 per share on September 8, 2025, also on unusually heavy trading volume [9].

Core Viewpoint - The Law Offices of Howard G. Smith is reminding investors about the deadline to file a lead plaintiff motion in a case concerning Quanex Building Products Corporation, specifically for those who purchased the company's securities during the defined class period from December 12, 2024, to September 5, 2025 [1] Group 1 - The deadline for filing a lead plaintiff motion is set for November 18, 2025 [1] - The case is on behalf of investors who suffered losses in Quanex Building Products Corporation (NYSE: NX) [1] - The class period for the securities involved spans from December 12, 2024, to September 5, 2025 [1]